Dr Katie Dale
Honorary (Senior Fellow)
Department of Infectious Diseases
25 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Projected Effects of Changing Global Tuberculosis Epidemiology on *Mycobacterium tuberculosis* Immunoreactivity Prevalence, 2024–2050
DOI: 10.3201/eid3203.2513402026
Journal article
A eureka moment – using coalface data for discovery on TB disease and financial relief
DOI: 10.5588/ijtldopen.25.05502025
Journal article
Why we should move away - not towards - symptom-based terminology and policy in tuberculosis.
DOI: 10.1093/cid/ciaf6672025
Journal article
Optimising the M72/AS01E tuberculosis vaccine candidate phase 3 trial based on the phase 2b trial results
DOI: 10.1016/j.vaccine.2025.1268162024
Journal article
Overlooked, dismissed, and downplayed: reversion of Mycobacterium tuberculosis immunoreactivity
DOI: 10.1183/16000617.0007-20242023
Journal article
The prevalence of tuberculosis infection among foreign-born Canadians: A modelling study
DOI: 10.1503/cmaj.2302282023
Journal article
Impact of Reversion of Mycobacterium tuberculosis Immunoreactivity Tests on the Estimated Annual Risk of Tuberculosis Infection
DOI: 10.1093/aje/kwad028
RECENT SCHOLARLY WORKS
2022
Journal article
Whole genome sequencing for tuberculosis in Victoria, Australia: A genomic implementation study from 2017 to 2020
DOI: 10.1016/j.lanwpc.2022.1005562022
Journal article
Estimating annual risk of infection with Mycobacterium tuberculosis
DOI: 10.1016/S1473-3099(22)00452-22022
Journal article
Modeling the Cost-Effectiveness of Latent Tuberculosis Screening and Treatment Strategies in Recent Migrants to a Low-Incidence Setting
DOI: 10.1093/aje/kwab150